Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands, Inc. (TLRY) closed at $1.91 in the latest trading session, marking a +1.6% move from the prior day.

Tilray Brands, Inc. (TLRY) Outperforms Broader Market: What You Need to Know

NEW YORK and LEAMINGTON, Ontario, July 15, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global lifestyle and consumer packaged goods company, today announced that the Company will release financial results for its fourth quarter and full fiscal year ended May 31, 2024 on July 29, 2024 at market close.

Tilray Brands, Inc. to Announce Fourth Quarter and Fiscal Year 2024 Financial Results on July 29, 2024

First Solar

Roku

There is some truth behind the old investment adage, “sell in May and go away.” The summer months tend to be stock market low points with September being one of the worst across all three major market indices.

The 3 Best Stocks to Buy for Q3 2024

Green Thumb Industries Inc.

Trulieve Cannabis Corp.

Looking to round out your portfolio with cool stock options? Consider these currently undervalued cannabis stocks.

The 3 Most Undervalued Cannabis Stocks to Buy in July 2024

Oklo Inc

Root

Many of yesterday's meme stocks, once the favorites of speculative traders, now sit forgotten at the bottom of portfolios, their potential for massive gains long gone. The popular sentiment — “It's only a loss if you sell” — offers little comfort in this scenario.

The 3 Best Meme Stocks to Buy in July 2024

AMC Entertainment

BlackBerry

Canopy Growth

Trump Media & Technology Group Corp

GameStop

Koss

Meme stocks looked to be on the comeback trail in May of this year after retail trader Keith Gill, known online as “Roaring Kitty,” made a triumphant return to social media after a three-year hiatus. By posting only a few cryptic memes heralding his return, Gill managed to more than double the share prices of popular undervalued meme stocks such as GameStop (NYSE: GME ) and AMC Entertainment (NYSE: AMC ).

The 7 Most Undervalued Meme Stocks to Buy in July 2024

Bitfarms Ltd

Joby Aviation

With the S&P 500 trading near all-time highs and the possibility of rate cuts, the meme stocks season is very much on the cards. Investors should, of course, remain focused on their core long term portfolio.

You've Been Warned! 3 Meme Stocks to Buy Now or Regret Forever

Cronos Group

Curaleaf Holdings, Inc.

As regulations gradually turn friendlier, the global cannabis market is at an inflection point of growth. By the end of the decade, there are likely to be several massive wealth creators among cannabis stocks.

Top Pot Picks: 3 Unstoppable Cannabis Stocks Set to Blaze Past Competition

TORONTO, July 10, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a leading global lifestyle and consumer packaged goods company, today announced that its Good Supply cannabis brand has released its updated lineup of flavourful 1G 510 vapes with phenomenal potency featuring a wide selection of the best flavours to choose from for 710 and beyond. Good Supply's 710 lineup of 1G 510 vapes includes the following flavour-forward favourites to explore: Banana Kush: A Kush to remember, featuring banana, citrus and earthy flavours Blue Dream: A classic that couldn't possibly ever get old, featuring berry, fruity sweetness Blue Raspberry: The perfect electric blend of sweet blueberries and cream Cherry Loops: Breakfast of champions featuring cherry, fruity, and citrus to fuel your day Frozen Watermelon: The perfect summer refresher featuring, cooling, fruity watermelon aromas Gooey Gold: A tasty combo of caramel, sugar and mocha Mango Passionfruit: A tropical goodness blend of Mango and Passionfruit Mountain Mist: Quench your thirst with this lemon, lime and orange throwback mix Orange Swirl: Take orange, vanilla and citrus for a spin – the perfect summer citrus treat in a vape Pineapple Express: Heady tropics with a hint of sweet and citrus notes Purple Monkey: An original Good Supply fan favourite, including fruity notes, with grape and citrus Rocket Bomb: A classic trio of cherry, lime, and blue raspberry Tropical Chewy Bear: Sweet, tropical and fruity nostalgia Good Supply is committed to promoting sustainability and an eco-conscious approach with its latest vape and product offerings.

Get Ready to Elevate Your Cannabis Experience With Good Supply's Latest Signature Vape Innovations

An election year means that talk of federal marijuana legalization is likely to ramp up in the months ahead. Multiple states, including Florida, could legalize recreational marijuana later this year.

Will the U.S. Election Help Give Tilray Brands and Canopy Growth a Year-End Boost?

Innovative Industrial Properties

Village Farms International

The cannabis market is set for significant growth, driven by increasing legalization and consumer demand. Several pot stocks are poised for high returns, reflecting broader market trends.

7 Pot Stock Pioneers Poised for High Returns

BERLIN, July 09, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, today announced a new Tilray-led scientific publication titled, Medical Cannabis for Patients Over Age 50: A Multi-Site, Prospective Study of Patterns of Use and Health Outcomes. The Medical Cannabis in Older Patients Study (“MCOPS”) is a multi-site, prospective, observational study examining the real-world impact of medical use on patients over the age of 50 and under the guidance of a healthcare provider.

Tilray Medical Announces Scientific Study on Medical Cannabis for Patients Over Age 50

Whatever your opinions on cannabis use might be, it seems as if the current administration has begun to soften the position of federally regulated cannabis. While several states have already legalized the drug for both medical and recreational use, its federal regulation has stood in the way of several high-potential cannabis stocks.

3 Cannabis Stocks Ready to Blaze as Regulations Ease

Ring Energy

Low-priced stocks are attractive as they provide an opportunity to create a diversified portfolio with limited funds. Additionally, there are speculative ideas among low-priced stocks that attracts investors for quick returns at the blink of an eye.

3 Stocks Under $3 That Can Trade in Double Digits in 2025

In the last five years, cannabis stocks have gone through small phases of euphoria that has been followed by a deep correction. There are two major challenges that have kept cannabis stocks depressed.

Budding Fortunes: 7 Cannabis Stocks With the Potential to Make You a Millionaire

Aurora Cannabis

Back in May, cannabis stocks briefly came back into vogue. This was due to a small amount of regulatory progress.

7 Cannabis Stocks to Sell in July Before They Crash & Burn

Curaleaf's Boris Jordan expects to see a lot of consolidation in the industry during the next decade. A lack of marijuana reform has made it difficult for cannabis companies to stay out of the red.

This Is What a Top Cannabis Executive Thinks Is Going to Happen in the Industry in the Next 10 to 15 Years

Apple Hospitality REIT

Riot Blockchain

Low-priced stocks with upside are increasingly hard to find as top-performing mega-caps edge ever closer to overvaluation. As seen with Nvidia (NASDAQ: NVDA ) recently, even moderate underperformance can be devastating when much of the wider market hinges on continued momentum.

3 Low-Priced Stocks With 100%+ Upside Potential

With a $2 billion valuation, Tilray Brands TLRY ranks as the largest cannabis company outside the U.S., leading in international sales and the Canadian recreational market. Pablo Zuanic of Zuanic & Associates has initiated coverage on Tilray with a 'Neutral' rating, highlighting the company's significant potential in global markets.

Is Tilray's $2B Valuation Just The Beginning? Analyst Sees $10B Market Opportunity, Initiates Coverage

Tilray Beverages announced the launch of Runner's High Brewing Company, a new non-alcoholic brand for those who love a great beer flavor without the buzz.

Tilray Brands Announces Runner's High Brewing Company – Its New Brand of Premium Non-Alcoholic Brews

The latest proposed rescheduling of marijuana on a federal level has placed cannabis stocks back in the spotlight. Join renowned analyst Pablo Zuanic, Co-Host of CNBC's Fast Money and portfolio manager of cannabis ETF CNBS Tim Seymour, and Best of Breed Growth Stock's Julian Lin to discuss ways to navigate this volatile and confusing sector.

Cannabis Investing In The Age Of Legalization

Investors have long been reading about cannabis stocks to buy. However, stocks in the sector have largely remained speculative plays.

3 Cannabis Stocks to Buy Before Regulations Get Super Friendly

TORONTO, June 26, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a leading global lifestyle and consumer packaged goods company, invites Canadians to elevate their July 1st celebrations with a curated selection of recreational cannabis products from beverages to flower, pre-rolls, and vapes. Whether there's a backyard barbecue, a beach day, or a cozy summer night stargazing with friends, Tilray Brands has the perfect products to enhance your summer festivities.

Celebrate Canada Day with Tilray Brands

The financial landscapes of Canadian and U.S. cannabis operators showcase distinct paths in the quest for profitability, driven by varying market dynamics and regulatory environments. According to recent financial data from Beacon Securities, the analysis of key financial metrics such as EV/EBITDA and P/CFO ratios reveals crucial insights.

Canadian Vs. U.S. Cannabis Companies: Who Is Winning The Market Race To Weed Profits?

Jazz Pharmaceuticals

With the federal government taking steps to reschedule cannabis to Schedule III, effectively creating a form of medical cannabis legalization, the future of  cannabis stocks is under intense scrutiny. While cannabis stocks initially surged on the news, they quickly settled back to their previous levels.

3 Cannabis Stocks That Could Make Your Grandchildren Rich

News for Tilray Brands Stock (TLRY)